Introduction
Quinone derivative compounds induce a broad spectrum of effects in humans and represent a class of toxicological intermediates, which may induce acute cytotoxicity, immunotoxicity, and carcinogenesis, and lead to cellular damage [1] . They can be formed from benzene or polycyclic aromatic hydrocarbons and are toxicologically important components of air pollution [2] and cigarette smoke [3] . Among the enzymes that modulate quinone toxicity, the NAD(P)H quinone oxidoreductase type 1 (NQO1; EC 1.6.99.2) is one of the most important enzymes. NQO1 is a homodimeric flavoenzyme that catalyses the obligatory twoelectron reduction of quinones to hydroquinones [4] . NQO1 activity can protect animal cells from the deleterious and carcinogenic effects of quinones by preventing the one-electron reduction of quinones by other reductases; however, prolonged exposure to environmental contamination, which contains quinones, damages pulmonary tissue and leads to airway inflammation and pathologies through an oxidative stress mechanism [5, 6] . NQO1 is mainly cytosolic but it has been described to be expressed at plasma membrane [7] . Semiquinone radicals of inhaled airborne particulate matter are believed to cause oxidative stress by generating reactive oxygen species (ROS), as reported in the lung [8] . Furthermore, diesel exhaust particles composed of polycyclic aromatic hydrocarbons and quinones are involved in a cellular ROS production associated with lung function impairment via a Nox4 redox-dependent mechanism [9] .
Nox4 belongs to the NADPH oxidase family that contains 7 members [10] [11] [12] . The function of those enzymes is exclusively dedicated to the production of ROS, which are essential signaling molecules. Primary discovered in kidney tissue [13] , Nox4 appears to be ubiquitously distributed. Its dysfunction has been linked to several pathologies including hypertension [14] , diabetes [15] , atherosclerosis [16] , cancer [17] , osteoarthritis [18] and inflammation [19] , and Nox4 represent a potential therapeutic target [20] . Despite its wide distribution, its activation mechanisms at the molecular level are unclear. It is of therapeutic interest to elucidate the mechanism of Nox4 NADPH oxidase activity. While activity of Nox1, Nox2, and Nox3 largely depends on the presence of cytosolic activator or organizer subunits, no well-known NADPH oxidase partners, beside p22 phox , have been identified or shown to activate Nox4 [21] [22] [23] . However, two partners of Nox4 have been described recently: the protein disulfide isomerase (PDI) and the polymerase DNA directed-delta-interacting protein (Poldip2). Nox4 is unique among other Nox isoenzymes in that its activity is constitutive and may depend on a specific conformation of the dehydrogenase DH domain that should allow a spontaneous transfer of electrons from NADPH to FAD and to the hemes [24, 25] . Data from various studies indicated clearly that Nox4 activity is regulated at the mRNA level, implying that an increase or decrease of ROS production by Nox4 is correlated to an up regulation [9, 16, [26] [27] [28] [29] [30] [31] [32] [33] or to a decline [34] of Nox4 transcripts. Although it has not been reported yet, post-translational regulation of Nox4 oxidase activity cannot be excluded.
In this study, we provide the first evidence that Nox4 activity can be modulated independently of both transcriptional and translational processes. We showed a dual effect of quinone compounds, as being activators or inhibitors of Nox4 ROS production depending on their redox potential (E). We suggest that quinones derivatives could modulate Nox4 activity by a redox regulation pathway. Moreover, NQO1 is introduced as an intermediate between quinones and Nox4 activation, suggesting a functional interaction between Nox4 and NQO1. The results argue in favor of a modulation of Nox4 activity by a new family of chemical compounds and suggest a potential role of Nox4 in pathologies implying quinone toxicity.
Materials and methods

Materials
Polyclonal antibody against 5-lipoxygenase (5-LO) (Cayman, Ann Arbor, USA) was a generous gift from F. Stanke (Grenoble, France). pEF6V5/HisB vector, penicillin, streptomycin, L-glutamine, Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), trypsin, Earles's balanced salts (EBSS), geneticin, Fluo-3/AM, BAPTA/ AM, and TRIzol 1 were purchased from Invitrogen (Cergy Pontoise, France). Blasticidin was from Funakoshi Co. (Japan); AMV reverse transcriptase was from QBiogene (Illkirch, France). Effectene transfection reagent was from Qiagen (Courtaboeuf, France). Luminol, ionomycin, horseradish peroxidase, thapsigargin, diphenyleneiodonium chloride (DPI), rotenone, Nv-nitro-L-arginine methyl ester hydrochloride (L-NAME), tiron, xanthine, benzoquinone (BQ), hydroquinone (HQ), 2,5-dimethyl-1,4-benzoquinone (tMetBQ), duroquinone, 2,5-di-tert-butyl-1,4-benzo-hydroquinone (tBuBHQ), 2,5-di-tert-butyl-1,4-benzoquinone (tBuBQ), 2-(12-hydroxydodeca-5,10-diynil)-3,5,6-trimethyl-p-benzoquinone (AA-861), 3, 3 0 -methylene-bis-4-hydroxycoumarin (Dicoumarol), cycloheximide (CHX) compounds were purchased from Sigma (Saint Quentin Fallavier, France). b-Mercaptoethanol was purchased from Carlo Erba (Val de Reuil, France). LightCycler FastStart DNA Master plus SYBR Green I kit, protease inhibitors cocktail tablet, tosyllysine-chloromethyl ketone (TLCK), NADPH, NADH, xanthine oxidase, and lactate dehydrogenase (LDH) optimized kits were purchased from Roche (Meylan, France). Leupeptin, pepstatin, and ECL reagents were from GE Healthcare (Orsay, France). UNI-ZAP human kidney lambda cDNA library was purchased from Stratagene (La Jolla, CA). Housekeeping gene GAPDH was purchased from BD Bioscience (Pont de Claix, France). SuperScriptIII first-strand synthesis was obtained from Life Technologies (Saint Aubin, France). tetracycline in the culture medium. Experiments were performed after the incubation at set times.
Cell culture
Isolation of human neutrophils
As previously reported [35] , human neutrophils were isolated from citrated venous blood of healthy volunteers. Blood samples were diluted twice in PBS (137 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 8 mM Na 2 HPO 4 pH 7.3) containing 1% (w/v) tri-sodium citrate, using a 33% (v/v) Hypaque-Ficoll gradient. After 20 min of centrifugation at 800 Â g at 20 8C, the pellet was submitted to a hypotonic lysis for 5-15 min in ice. After 5 min of centrifugation at 350 Â g at 4 8C, the neutrophil pellet was collected and washed once in PBS. Neutrophils were suspended in PBS containing 0.2% (w/v) BSA and 0.5 mM CaCl 2 at a concentration of 10 7 cells/mL and used for superoxide measurement by chemiluminescence and protein extraction.
Generation of plasmid constructs for Nox4 and NQO1 isoforms expression
Two Nox4 cDNAs were characterized by PCR using UNI-ZAP human kidney lambda cDNA library (Stratagene) as template. Nox4A corresponds to the full length Nox4 usually described (Genbank TM accession number: AF254621), and Nox4B is the 14 spliced exon isoform (Genbank TM accession number: AY288918).
Two NQO1 cDNAs were characterized by RT-PCR from mRNA extracts of Nox4 T-REx TM cells, NQO1A (no. access NP_000894.1) and NQO1C (no. access NP_001020605.1). Nox4A, Nox4B, NQO1A, and NQO1C were cloned into pEF6V5/HisB for mammalian expression as described [18] . [18] . Real time RT-PCR was conducted using the LightCycler 1 CarouselBased System (Roche) or a Stratagene Mx3005P (Stratagene). Briefly, the expression levels of human Nox4, NQO1 and housekeeping GAPDH, RPL27 and RPL32 mRNAs were determined using specific primers chosen to include intron spanning (Table 1) . PCRs were carried out for each sample in triplicate. Gene expression was quantified using the comparative threshold cycle (Ct) method. The amount of target gene, normalized to three endogenous reference genes (RPL27, RPL32 and GAPDH) was expressed relative to the control cells, as indicated in Figures. The specificity of the products was confirmed for each fragment by a melting curve analysis and gel electrophoresis.
Protein extraction
Two methods were used. First, HEK293E cells were harvested and lysed on ice in 1% (p/v) Triton X-100 buffer (20 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, pH 7.6), containing a protease inhibitor cocktail containing 2 mM leupeptin, 2 mM pepstatin, and 10 mM TLCK l, for 20 min at 4 8C. The lysate was then centrifuged at 10,000 Â g for 10 min at 4 8C and supernatant was used for Western blotting experiments. Second, human neutrophils were suspended at a concentration of 5 Â 10 8 cells/mL in PBS containing the protease inhibitor cocktail. The cells were sonicated for 3 Â 10 s at 4 8C and 40 W using a Branson sonifier. The homogenate was centrifuged at 1000 Â g for 15 min at 4 8C to remove unbroken cells and nuclei. The post-nuclear supernatant was centrifuged at 200,000 Â g for 1 h at 4 8C. The pellet consisting of crude membranes was suspended in the same buffer.
SDS-PAGE and Western blot
The Triton X-100 soluble extract, membrane or cytosol fractions were loaded on a 7% or 10% SDS-PAGE and electro-transferred to nitrocellulose, as previously described. Immunodetection was performed using primary polyclonal antibodies against 5-lipoxygenase (dilution 1:2000) following by a secondary antibody combined with horseradish peroxidase. The bound peroxidase activity was measured using ECL reagents.
Determination of ROS production by chemiluminescence
ROS production was measured as previously described [18] . Cells were washed twice with PBS, detached with trypsin, and collected by centrifugation (250 g, 5 min at 20 8C). stimulating agents (Nox2). For the xanthine-xanthine oxidase assay, ROS production was measured as previously in a medium containing luminol and horse radish peroxidase plus 1 mM Xanthine and 0.75 mUI Xanthine oxidase in the presence or not of quinones.
Intracellular free Ca 2+ measurement
Intracellular free Ca 2+ levels were measured by flow cytometry (FACSCalibur, Becton Dickinson cytometer) using Fluo-3/AM. The fluorescence intensity of Fluo-3/AM dye was detected in the gated cell population at 526 nm (FL1 channel), which is proportional to the intracellular free calcium level. Cells were harvested and then counted. 10 7 cells/mL, suspended in Tyrode's «free» buffer (10 mM HEPES, 145 mM NaCl, 2.5 mM KCl, 10 mM glucose, 1.2 mM MgCl 2 , pH 7.3) were incubated in a light free environment with 10 mM of Fluo-3/AM for 30 min at 37 8C before analysis. After washing cells with the Tyrode's ''free'' buffer containing 1.5 mM CaCl 2 or 1 mM EGTA, basal fluorescence was measured at 526 nm for 1 min. Chemical compounds were added to the tubes containing 5 Â 10 6 cells per 500 ml, and measurement was continued for 5 more minutes. The data analysis was performed as follow: gates (5 s) were created along the time axis of the dot plots windows at defined time points, and the mean fluorescence intensity was statistically analyzed for every gate (WinMDI 2.8 software).
Lactate dehydrogenase (LDH) activity measurement
The activity of LDH was measured in the incubation medium as an index of plasma membrane integrity. Cells were washed twice with PBS, detached with trypsin, collected by centrifugation (250 g, 5 min at 20 8C), and counted. In a 96-well plate, 5 Â 10 5 cells per well were resuspended in 250 ml of PBS.
Cells were incubated with quinone compounds at different concentrations for 60 min. At the end of the treatment period, supernatants were collected and assessed for LDH activity on a Hitachi/MODULAR automated analyzer using the Roche optimized kit. The cell viability was expressed as the percentage of LDH released into the incubation medium versus total cell activity measured after cell lysis with 1% (v/v) Triton-X 100.
Statistical analysis
Data were expressed as the mean AE SD. Statistical analysis was performed using Mann and Whitney or Kruskal and Wallis tests. The results are reported when significantly different (p < 0.05) from control.
Results
Overexpression of Nox4 in HEK293E cell line and constitutive NADPH oxidase activity
Nox4 was identified for the first time in tubular cells of adult kidney and its oxidase activity was shown to be constitutive [13] . We, therefore, performed the functional characterization of Nox4 in HEK293E (human embryonic kidney) cell line which expresses Nox4 mRNA but not Nox1 and Nox2, (unpublished data). The oxidase activity of these cells was very low and was not sensitive to PMA (unpublished data). We stably overexpressed two isoforms of Nox4, Nox4A the active isoform (Genbank TM accession number:
AF254621), and a splicing variant Nox4B (Genbank TM accession number: AY288918) that is unable to produce ROS due to the absence of one NADPH binding sites [36] . The results showed a significant increase of mRNA expression encoding both Nox4 isoforms compared to WT cells (Fig. 1A) . While the overexpression of Nox4B failed to produce ROS, Nox4A demonstrated a spontaneous ROS generation compared to WT-HEK293E cells (Fig. 1B) and that corresponded to a NADPH oxidase activity since it was solely inhibited by DPI (inhibitor of flavoproteins) and Tiron (superoxide scavenger) but not by rotenone (mitochondrial respiratory chain inhibitor) and L-NAME (competitive inhibitor of NO synthase) (Fig. 1C ).
Stimulation of Nox4 activity by two quinone derivatives
Next, we evaluated the effect of two quinone compounds, AA-861 and tBuBHQ on Nox4 constitutive activity. Incubation of Nox4A-HEK293E cells with AA-861 or tBuBHQ led to an increase of ROS production ( Fig. 2A) . The stimulated activity reached its optimum level at 10 min or 20 min after AA-861 or tBuBHQ incubation respectively. The incubation with WT-HEK293E cells did not lead to a high level of ROS production. In fact, only small increase of ROS was observed reflecting the stimulation of the endogenous Nox4 by those two quinones ( Fig. 2A, inset) . The specificity of a NADPH oxidase activity was confirmed by using DPI which had an inhibitory effect whereas rotenone and L-NAME did not ( Fig. 2A) .
To confirm that the observed effect of AA-861 and tBuBHQ was specifically related to Nox4 proteins, we used two other characterized cell lines that over-expressed Nox4: human chondrocyte C-20/A4 [18] and Nox4 T-REx TM in which Nox4 expression could be temporally induced by the addition of tetracycline [27] . Consistently, the constitutive ROS production in Nox4 C-20/A4 cells or in 4 h-induced Nox4 T-REx cells was enhanced after the addition of AA-861 or tBuBHQ ( Fig. 2B and C) . It is noticeable that the ROS production of uninduced T-REx TM cells, which do not express Nox4, was not affected by AA-861 or by tBuBHQ indicating that those two quinones do not produce ROS spontaneously in the presence of cells (Fig. 2C) . Considering the short time course of AA-861 and tBuBHQ stimulation, it is unlikely that the augmentation of Nox4 activity observed was correlated to an increase of its protein expression. However, to rule out this eventuality, we inhibited Nox4 protein synthesis by using cycloheximide (CHX), an inhibitor of protein translation. The time course of the Nox4 mRNA expression induced by tetracycline indicated that the maximum level was reached at 4 h and then remained constant until 8 h (Fig. 2D) . After 2 h of Nox4 induction by tetracycline, time point when the Nox4 mRNA synthesis is still increasing, CHX was added in the medium of Nox4 T-REx TM cell line and oxidase activity was measured after two additional hours of incubation. As expected, CHX-treated cells exhibited a lower constitutive oxidase activity (66%), indicating a lower amount of induced Nox4 proteins, compared to non-CHX-treated cells (Fig. 2E, white bars) . Although an increase of Nox4 protein was abolished under CHX treatment, Nox4 activity was still stimulated by AA-861 incubation (Fig. 2E , black bars compared to white). These results support our above consideration that AA-861 specifically increases Nox4 activity independently of its protein level. Since AA-861 was described as a 5-lipoxygenase (5-LO) inhibitor, we investigated whether 5-LO could be implicated in the stimulation of Nox4 activity. 5-LO was originally reported to be expressed in leucocytes and some epithelial cells [37] , but no data concerning 5-LO expression in the HEK293E cell line are available. We found that neither 5-LO mRNA nor 5-LO protein was expressed in HEK293E cells (Fig. 3A and B) , which excludes the involvement of 5-LO in Nox4 activation by AA-861. Furthermore, MK-886, another 5-LO inhibitor did not modulate Nox4 activity (unpublished observations).
The relationship between calcium ion flux and Nox4 activity has not been clearly described. Pedruzzi et al. [16] reported that Nox4 activity located in the endoplasmic reticulum was concomitant to Ca 2+ oscillation after exposure to 7-ketocholesterol. However in a previous study, we showed that ionomycin (calcium ionophore) had no effect on the Nox4 activity in chondrocytes C-20/A4 cells over-expressing Nox4A [18] . Since tBuBHQ was described as a SERCA pump inhibitor, it is necessary to evaluate the potential contribution of the Ca 2+ flux on Nox4 stimulation. To this purpose, we measured the calcium flux in Nox4-HEK293E cells by FACs using a fluorescent Fluo-3/AM probe and compared the calcium changes to Nox4 activation. As illustrated in the figure 3 ( Fig. 3C and D) , an increase of cytosolic calcium from intracellular stores was observed in the presence of extracellular EGTA after adding ionomycin, thapsigargin or tBuBHQ whereas the addition of AA-861 or tBuBQ, two compounds that stimulate Nox4 activity were unable to modify Ca 2+ level. Furthermore, thapsigargin or ionomycin could not modulate the constitutive activity of Nox4 in Nox4-HEK293E cells (Fig. 3E) . Same experiments were performed in the presence of 1.5 mM CaCl 2 in the extracellular medium without EGTA and led to the same results (unpublished observations). These data strongly suggest that there is no correlation between Ca 2+ flux and Nox4 activity.
Quinone structure may be responsible for the modulation of Nox4 activity
AA-861 and tBuBHQ share the same quinone moiety. To evaluate whether quinone structure was responsible for Nox4 activation, the ROS production by Nox4-HEK293E cells was in presence of 1 mM EGTA and then the ROS production was measured by chemiluminescence. Results are expressed as the sum of RLU measurements for 90 min. measured after incubation with various quinone derivatives that differ with respect to their reduced or oxidized state and substitution levels. The results shown in Table 2 illustrate two opposite effects. Duroquinone as well as tBuBHQ, tBuBQ (the oxidative form of tBuBHQ), and AA-861, stimulated Nox4 activity at a starting concentration of 1 mM, whereas BQ (30 mM), HQ (30 mM) and tMetBQ (100 mM) inhibited this activity in a dose dependent manner. We also confirmed the inhibitory effect of the naphthoquinone, plumbagin, on Nox4 activity as reported [38, 39] .
To exclude a non-specific spontaneous ROS production by quinone compounds in contact with membrane phospholipids as described for tBuBHQ [40] , we measured the ROS synthesis in the presence of 25 mg phosphatidylcholine. The results illustrated in Table 3 show that there was no ROS enhancement by quinones after addition of phospholipids versus control, except for a slight increase observed as expected with tBuBHQ, as previously reported [40] . Furthermore, quinone concentrations used in this study were not cytotoxic as examined by the LDH activity (Table 3) .
Effect of quinones on Nox2
We next evaluated whether those quinones could affect Nox2 oxidase activity in isolated human neutrophils which express only Nox2, the redox core of phagocyte NADPH oxidase. Compared to the well known activator PMA, no NADPH oxidase activation was observed when neutrophils were incubated with AA-861, tBuBQ, or duroquinone (Fig. 4A) as opposed to what was previously observed in Nox4 T-REx TM cells (Table 2) . However, slight oxidase activation was observed upon the addition of tBuBHQ, probably due to its effect on the calcium flux since thapsigargin, another SERCA pump inhibitor, or ionomycin gave similar results (unpublished data). On the contrary, the quinones BQ, HQ, tMetBQ, and plumbagin also inhibited the PMA stimulated neutrophil oxidase activity (Fig. 4B) . By using an in vitro xanthine/xanthine oxidase superoxide production system, we observed that the ROS production was abolished in the presence of 30 mM BQ, 30 mM HQ, and 100 mM tMetBQ while no effect on the xanthine/xanthine oxidase ROS production was noticeable with 50 mM duroquinone, 50 mM tBuBHQ, 50 mM tBuBQ, or 10 mM AA-861 (unpublished data). Using differentiated PLB-985 as another cellular model, we obtained similar results than those observed with human PMN (Fig. 4C) . We, next, evaluated whether quinones could increase Nox2 activity already activated by the physiological agonists (the formylated peptide fMLP) in differentiated PLB-985 cells and found that AA-861, tBuBQ, and duroquinone did not stimulate Nox2 activity (Fig. 4D) . These results suggest that BQ, HQ, and tMetBQ inhibit ROS production through an antioxidant property. On the contrary, duroquinone, tBuBHQ, tBuBQ, and AA-861 appear to stimulate specifically NADPH oxidase activity of Nox4.
Putative quinone binding site (Q site) on Nox4
Quinones compounds bind to its target proteins through well described ubiquinone binding sites [41] . Based on computational prediction, a consensus sequence for a predictable quinone binding site or Q site was suggested: ''aliphatic-(X) 3 -H-(X) 2-3 -(Leu/Thr/ Ser)'' [42] . The analysis of the Nox4 protein sequence showed a similar putative motif in the fifth transmembrane domain ('' 203 LLTLHVS 209 '') that is missing in Nox2 sequence (Fig. 5A) .
Therefore, quinones could regulate Nox4 activity by binding directly to the protein through this putative domain. To investigate the relevance of this potential Q site in Nox4 protein, we mutated key amino acid residues of that sequence, i.e., substitutions of L203G and S209A (Fig. 5A) . Our results showed that those mutations did not modify the stimulatory effect of the quinone tBuBHQ on Nox4 activity which remained similar to WT Nox4 (Fig. 5B ). Since our data showed that quinones did not activate Nox2 activity nor enhance its activity (Fig. 4) (Fig. 5B) . Those results suggest that this putative Q site domain on Nox4 is not involved in the stimulation of Nox4 activity by quinone compounds.
Redox regulation of Nox4 activity
A recent study [43] showed that structural modifications of the E-loop, by deletion or exchange of cysteine, had an impact on the production rate and nature of ROS generated. The authors hypothesized that extracellular cysteines C226 and C270 might form a disulfide bridge that modulates Nox4 ROS production. Quinones compounds are highly reducing molecules capable of breaking disulfide bridges and, therefore, could modulate Nox4 activity through a redox regulation. To test this hypothesis, we measured the effect of known reducing agents on Nox4 activity and found that in tet-induced Nox4 T-REx TM cells, the addition of 80 mM NADPH, NADH, or b-mercaptoethanol increased significantly the ROS production compared to non-induced and untreated Nox4 T-REx TM cells (Fig. 5C ). These results suggest that reducing agents stimulate Nox4 activity and point out a possible mechanism by which quinones might regulate Nox4 activity by reducing the E-loop disulfide bridge.
Involvement of NQO1 on Nox4 activation by quinone
Quinone compounds are metabolized through different pathways and one of them involves the NAD(P)H oxidoreductase 1 (NQO1). By RT-PCR and sequencing, we revealed that Nox4 TREx TM cells expressed two types of mRNA encoding for NQO1:N-QO1A, the active form and NQO1C, the inactive form, which lacks 2 essential amino acid residues (Tyrosine-126 and -128) necessary for its quinone binding capacity [4] . To investigate the potential role of NQO1 in the stimulation of Nox4 activity by quinone compounds, we used dicoumarol to inhibit NQO1. Pre-incubation of the tetracycline induced Nox4 T-REx TM cells with 100 mM dicoumarol inhibited Nox4 constitutive activity as well as its stimulation by tBuBHQ (Fig. 6A) . To further investigate the role of NQO1, we stably overexpressed NQO1A and NQO1C in Nox4-HEK293 and confirmed the presence of the exogenous NQO1A and NQO1C mRNA in the corresponding transfected cells compared with the empty vector control transfected cells (Fig. 6B) . Furthermore, by real time RT-PCR we showed the mRNA level of NQO1A and NQO1C increased 2 and 8 fold, respectively, compared to the control Nox4-HEK293 cells (Fig. 6B) . We then investigated the consequences of these overexpressions on Nox4 activity. Results showed that overexpression of NQO1A enhanced twice the stimulatory effect of tBuBHQ on Nox4 activity compared to the control empty vector cells. This is consistent with the increase level of NQO1A mRNA observed previously (Fig. 6B) . On the contrary, although the overexpression of NQO1C is higher than that of NQOA, it did not modify the stimulatory effect which is comparable to that observed with the control empty plasmid (Fig. 6C) . Together, these data suggest the implication of NQO1 enzymes in quinone-stimulated Nox4 activity.
Discussion
Our study focuses on the capacity of quinone compounds to modulate the NADPH oxidase activity of Nox4. Quinones are important toxic compounds present in air pollution and abundant in all burnt organic material, including urban air particles, cigarette smoke, and diesel exhaust particles (DEP) [44] . DEP were reported to increase Nox4 ROS production after 1 h of incubation, suggesting the implication of Nox4 in the quinone metabolism [9] . Considering the structure/function relationship of the quinones used in this study (Table 2) , we observed a dual stimulation/ inhibition effect that depends on their substitution state: Nox4 activity was stimulated by AA-861, duroquinone, tBuBQ, and tBuBHQ whereas other less substituted derivatives such as BQ, HQ, tMetBQ, and plumbagin, developed antioxidant properties ( Table 2 ). The specificity of AA-861, duroquinone, and tBuBQ for Nox4 over Nox2, suggests either a direct effect of quinone derivatives in the molecular dynamics of electron transfer mediated by Nox4, or an indirect role on a quinone sensitive functional partner of Nox4. In this work, we suggest a new aspect of Nox4 oxidase activity regulation that takes place not only at a transcriptional level as usually described [13, 27, 45] but also at a post-translational level as described above with quinone molecules. Quinones are bioreactive molecules that are sensitive to redox mechanism. Ubiquinone, for example, is a mobile electron carrier of mitochondria and a highly hydrophobic molecule that diffuses into the core of inner membrane where the electron transfer proceeds through a Q cycle on either side of membrane [41, 46] . A predictable quinone binding site has been suggested [42] and we identified a similar domain in Nox4 protein sequence '' 203 LLTLHVS 209 ''. However, the implication of such domain was not confirmed since the ability of quinones to stimulate Nox4 activity was not abolished when appropriate residues of this sequence were mutated ( Fig. 5A and B) . Alternatively, Takac and his colleagues [43] have shown that disulfide bridges formed by two cysteines C226 and C270 may be involved in the maintenance of the extracellular E-loop integrity. Indeed, the disruption of the bridge by mutagenesis modified notably Nox4 ROS production [43] . Disulfide bridges with a standard redox potential (E 0 ) of À180 mV [47] could be reduced by NADPH, NADH and b-mercaptoethanol that possess a lower E 0 (À324, À320, and À253 mV, respectively) [48] . Our results using those reducing agents indicated that Nox4 activity could be stimulated by extracellular redox modifications, possibly through the reduction of its disulfide bridge. Interestingly, duroquinone, which enhances Nox4 activity, has a low E 0 (À260 mV) [49] and then could theoretically reduce disulfide bridge. Conversely, compounds such as BQ, HQ and tMetBQ that do not stimulate Nox4 exhibit a higher E 0 , 78 mV, 78 mV and À67 mV, respectively, compared to that of the disulfide bridge. Thus, it is possible that quinones exhibiting an E 0 lower than that of disulfide bridge are able to stimulate Nox4 activity.
NAD(P)H-quinone oxidoreductase-1 (NQO1) is a broadly distributed FAD-dependent flavoprotein that catalyses the reduction of a wide variety of quinone compounds. It reduces quinones, by the transfer of 2 electrons, to the corresponding hydroquinones which are the electron donor state capable to initiate reductive reactions. We showed that NQO1 is expressed in uninduced or tetinduced Nox4 T-REx TM cells; however, the stimulation of ROS production by quinones occurs only when Nox4 expression was induced. Moreover, the increase of Nox4 ROS production by quinones was inhibited by a well known inhibitor of NQO1, dicoumarol. Noticeably, dicoumarol also decreases Nox4 constitutive activity in quinone-untreated Tet-induced Nox4 T-REx TM cells (Fig. 6A ), possibly by inhibiting the endogenous NQO1 enzymes. More specifically, only the functional NQO1 enzyme, NQO1A, enhanced the ROS production of Nox4 induced by quinone compounds (Fig. 6C) . Interestingly, NQO1 has been described to partition between cytosol and plasma membrane [7] where Nox4 is also located in HEK293 cells [50] . These observations suggest a potential link between NQO1 and Nox4. Such potential link could be illustrated in pancreatic cancer. Pancreatic cancer is very aggressive and unresponsive to treatments due to a resistance of cells to apoptosis. Vaquero et al. [51] reported that ROS produced by Nox4 are prosurvival and antiapoptotic for human pancreatic adenocarcinoma cell lines, MIA PaCa-2 and PANC-1. In the MIA PaCa-2 cell line, Lewis et al. [52] showed that inhibition of NQO1 by dicoumarol suppresses the malignant phenotype of pancreatic cancer cells and induces cell apoptosis. Finally, our study described 4 quinones derivatives especially AA-861 and tBuBHQ capable of enhancing Nox4 ROS production. We showed that NQO1 may be involved in the stimulation of Nox4 ROS production induced by quinones. We further observed that Nox4 activity is also stimulated in the presence of reducing agents that may possibly act by reducing the disulfide bridge located in the extracellular E-loop of Nox4. All together, we hypothesize that in the presence of quinones, NQO1 may generate hydroquinone forms, providing, therefore, potential reducing agents near Nox4 protein. Depending on the quinone redox potential, Nox4 E-loop disulfide bridge could be disrupted consequently leading to the increase of its oxidase activity. However, the direct implication of the E-loop disulfide bridge needs further investigations. The proposed model could provide new insight into the understanding of molecular mechanism of the electron transfer through Nox4 and also define new therapeutic targets in diseases in which quinones and Nox4 are implicated.
